José Angel Obeso
#118,892
Most Influential Person Now
José Angel Obeso's AcademicInfluence.com Rankings
José Angel Obesomedical Degrees
Medical
#1762
World Rank
#2136
Historical Rank
Neurology
#157
World Rank
#224
Historical Rank
José Angel Obesophilosophy Degrees
Philosophy
#5309
World Rank
#8071
Historical Rank
Logic
#2609
World Rank
#3622
Historical Rank
Download Badge
Medical Philosophy
José Angel Obeso's Degrees
- Doctorate Medicine University of Cantabria
Why Is José Angel Obeso Influential?
(Suggest an Edit or Addition)José Angel Obeso's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- MDS clinical diagnostic criteria for Parkinson's disease (2015) (3560)
- Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease. (2001) (1429)
- MDS research criteria for prodromal Parkinson's disease (2015) (897)
- Goal-directed and habitual control in the basal ganglia: implications for Parkinson's disease (2010) (885)
- Pathophysiology of the basal ganglia in Parkinson's disease (2000) (800)
- Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms (2009) (757)
- Missing pieces in the Parkinson's disease puzzle (2010) (697)
- Selective neuronal vulnerability in Parkinson disease (2017) (626)
- Functional organization of the basal ganglia: Therapeutic implications for Parkinson's disease (2008) (541)
- Lewy body extracts from Parkinson disease brains trigger α‐synuclein pathology and neurodegeneration in mice and monkeys (2014) (522)
- Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy (2017) (502)
- Continuous dopamine-receptor treatment of Parkinson's disease: scientific rationale and clinical implications (2006) (486)
- Levodopa motor complications in Parkinson's disease (2000) (483)
- Functional neuroanatomy of the basal ganglia. (2012) (471)
- The subthalamic nucleus in Parkinson's disease: somatotopic organization and physiological characteristics. (2001) (467)
- Chaperone-mediated autophagy markers in Parkinson disease brains. (2010) (463)
- The impact of deep brain stimulation on executive function in Parkinson's disease. (2000) (441)
- A fronto–striato–subthalamic–pallidal network for goal-directed and habitual inhibition (2015) (406)
- Temporal discrimination is abnormal in Parkinson's disease. (1992) (402)
- Long‐term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease (2010) (400)
- Priorities in Parkinson's disease research (2011) (391)
- Time to Redefine PD? Introductory Statement of the MDS Task Force on the Definition of Parkinson's Disease (2014) (384)
- Levodopa in the treatment of Parkinson's disease: Current controversies (2004) (370)
- Time estimation and reproduction is abnormal in Parkinson's disease. (1992) (367)
- Chronic dopaminergic stimulation in Parkinson's disease: from dyskinesias to impulse control disorders (2009) (336)
- Step initiation in Parkinson's disease: Influence of levodopa and external sensory triggers (1997) (332)
- The basal ganglia in Parkinson's disease: Current concepts and unexplained observations (2008) (326)
- Challenges in Parkinson's disease: restoration of the nigrostriatal dopamine system is not enough (2004) (324)
- Coupling between Beta and High-Frequency Activity in the Human Subthalamic Nucleus May Be a Pathophysiological Mechanism in Parkinson's Disease (2010) (317)
- Slow oscillatory activity and levodopa-induced dyskinesias in Parkinson's disease. (2006) (310)
- Novel pharmacological targets for the treatment of Parkinson's disease (2006) (304)
- Deep brain stimulation: from neurology to psychiatry? (2010) (289)
- Re-evaluation of the functional anatomy of the basal ganglia in normal and Parkinsonian states (1997) (287)
- Subthalamotomy in parkinsonian monkeys. Behavioural and biochemical analysis. (1996) (247)
- Pathophysiology of levodopa-induced dyskinesias in Parkinson's disease: problems with the current model. (2000) (243)
- Impulse control disorders and levodopa-induced dyskinesias in Parkinson's disease: an update (2017) (227)
- Levodopa‐induced dyskinesias in Parkinson's disease: Clinical and pharmacological classification (1992) (220)
- Bilateral subthalamotomy in Parkinson's disease: initial and long-term response. (2005) (195)
- Involvement of the subthalamic nucleus in impulse control disorders associated with Parkinson's disease. (2011) (194)
- Milestones in research on the pathophysiology of Parkinson's disease (2011) (192)
- Influence of microRNA deregulation on chaperone-mediated autophagy and α-synuclein pathology in Parkinson's disease (2013) (191)
- Timing of treatment initiation in Parkinson's disease: A need for reappraisal? (2006) (186)
- Deficits in inhibitory control and conflict resolution on cognitive and motor tasks in Parkinson’s disease (2011) (183)
- Efficacy of deep brain stimulation of the subthalamic nucleus in Parkinson’s disease 4 years after surgery: double blind and open label evaluation (2004) (175)
- The origin of motor fluctuations in Parkinson’s disease (2004) (174)
- Basal ganglia pathophysiology. A critical review. (1997) (171)
- The Subthalamic Nucleus and Tremor in Parkinson's Disease (2008) (167)
- Movement disorders (1998) (164)
- Consequences of Nigrostriatal Denervation on the Functioning of the Basal Ganglia in Human and Nonhuman Primates: An In Situ Hybridization Study of Cytochrome Oxidase Subunit I mRNA (1997) (162)
- Motor complications associated with chronic levodopa therapy in Parkinson's disease. (1989) (157)
- Impact of deep brain stimulation on upper limb akinesia in Parkinson's disease (1999) (152)
- Continuous dopamine-receptor stimulation in advanced Parkinson's disease (2000) (148)
- Compensatory mechanisms in Parkinson's disease: Circuits adaptations and role in disease modification (2017) (145)
- The expanding universe of disorders of the basal ganglia (2014) (145)
- The evolution and origin of motor complications in Parkinson's disease. (2000) (144)
- Changing the research criteria for the diagnosis of Parkinson's disease: obstacles and opportunities (2013) (144)
- Long‐term effects of pallidal or subthalamic deep brain stimulation on quality of life in Parkinson's disease (2009) (142)
- The subthalamic nucleus, hemiballismus and Parkinson's disease: reappraisal of a neurosurgical dogma. (2001) (139)
- Parkinson's Disease Is Not Simply a Prion Disorder (2017) (139)
- Pathophysiologic basis of surgery for Parkinson's disease. (2000) (137)
- Effects of l-DOPA on preproenkephalin and preprotachykinin gene expression in the MPTP-treated monkey striatum (1995) (134)
- Focused ultrasound subthalamotomy in patients with asymmetric Parkinson's disease: a pilot study (2018) (133)
- Performance of repetitive wrist movements in Parkinson's disease. (1992) (132)
- Preventing levodopa-induced dyskinesias. (2000) (132)
- The subthalamic nucleus is involved in successful inhibition in the stop-signal task: A local field potential study in Parkinson's disease (2013) (132)
- Therapeutic efficacy of unilateral subthalamotomy in Parkinson’s disease: results in 89 patients followed for up to 36 months (2009) (132)
- Restoration of thalamocortical activity after posteroventral pallidotomy in Parkinson's disease (1994) (129)
- Drug Insight: continuous dopaminergic stimulation in the treatment of Parkinson's disease (2006) (129)
- The anatomical basis of somaesthetic temporal discrimination in humans. (1991) (129)
- The basal ganglia and disorders of movement: pathophysiological mechanisms. (2002) (126)
- Is Parkinson's Disease a Vesicular Dopamine Storage Disorder? Evidence from a Study in Isolated Synaptic Vesicles of Human and Nonhuman Primate Striatum (2014) (125)
- Grey matter hypometabolism and atrophy in Parkinson's disease with cognitive impairment: a two-step process. (2014) (118)
- The role of deep brain stimulation as a surgical treatment for Parkinson's disease. (2000) (118)
- Targeting the basal ganglia for deep brain stimulation in Parkinson's disease. (2000) (117)
- High beta activity in the subthalamic nucleus and freezing of gait in Parkinson's disease (2014) (110)
- Dopamine Cell Degeneration Induced by Intraventricular Administration of 6-Hydroxydopamine in the Rat: Similarities with Cell Loss in Parkinson's Disease (2001) (109)
- Deep brain stimulation of the globus pallidus pars interna in advanced Parkinson's disease. (2000) (108)
- Does neuromelanin contribute to the vulnerability of catecholaminergic neurons in monkeys intoxicated with MPTP? (1993) (106)
- Metabolic activity of the basal ganglia in parkinsonian syndromes in human and non-human primates: A cytochrome oxidase histochemistry study (1996) (105)
- Extensive loss of brain dopamine and serotonin induced by chronic administration of MPTP in the marmoset (1991) (103)
- LISURIDE INFUSION PUMP: A DEVICE FOR THE TREATMENT OF MOTOR FLUCTUATIONS IN PARKINSON'S DISEASE (1986) (101)
- Metabolic effects of nigrostriatal denervation in basal ganglia (2000) (101)
- Pulsatile stimulation of dopamine receptors and levodopa-induced motor complications in Parkinson's disease: implications for the early use of COMT inhibitors. (2000) (99)
- Time to move beyond nigrostriatal dopamine deficiency in Parkinson's disease (2004) (99)
- Current applications and limitations of surgical treatments for movement disorders (2017) (97)
- Movement disorder society criteria for clinically established early Parkinson's disease (2018) (96)
- Posterior parietooccipital hypometabolism may differentiate mild cognitive impairment from dementia in Parkinson’s disease (2012) (95)
- Subcutaneous lisuride infusion in Parkinson's disease. Response to chronic administration in 34 patients. (1991) (92)
- Consequence of nigrostriatal denervation and L-dopa therapy on the expression of glutamic acid decarboxylase messenger RNA in the pallidum (1996) (92)
- The subthalamic nucleus: A possible target for stereotaxic surgery in parkinson's disease (1993) (92)
- Levodopa in the treatment of Parkinson's disease: A consensus meeting viewpoint (1999) (90)
- When Do Levodopa Motor Fluctuations First Appear in Parkinson’s Disease? (2010) (90)
- Thalamic innervation of the direct and indirect basal ganglia pathways in the rat: Ipsi‐ and contralateral projections (2005) (89)
- Bidirectional gut-to-brain and brain-to-gut propagation of synucleinopathy in non-human primates. (2020) (86)
- The pathophysiological basis of sensory disturbances in Parkinson's disease (2010) (86)
- Clinical pattern and risk factors for dyskinesias following fetal nigral transplantation in Parkinson's disease: A double blind video‐based analysis (2009) (86)
- The nigrostriatal system in the presymptomatic and symptomatic stages in the MPTP monkey model: A PET, histological and biochemical study (2012) (85)
- Reciprocal inhibition between forearm muscles in spastic hemiplegia (1991) (85)
- No Lewy pathology in monkeys with over 10 years of severe MPTP Parkinsonism (2009) (85)
- Homocysteine and cognitive impairment in Parkinson's disease: A biochemical, neuroimaging, and genetic study (2009) (83)
- Surgery for Parkinson's disease. (1997) (83)
- Clinical and pathological features of Parkinson's disease. (2015) (83)
- The subthalamic nucleus and inhibitory control: impact of subthalamotomy in Parkinson's disease. (2014) (82)
- Dopaminergic transplantation for parkinson's disease: Current status and future prospects (2009) (82)
- A Cortical Pathogenic Theory of Parkinson’s Disease (2018) (82)
- Thalamic innervation of striatal and subthalamic neurons projecting to the rat entopeduncular nucleus (2004) (81)
- The role of pulsatile versus continuous dopamine receptor stimulation for functional recovery in Parkinson's disease. (1994) (81)
- How does Parkinson's disease begin? The role of compensatory mechanisms (2004) (80)
- Motor behavioural changes after intracerebroventricular injection of 6-hydroxydopamine in the rat: an animal model of Parkinson's disease (2001) (79)
- Hyperkinetic disorders and loss of synaptic downscaling (2016) (79)
- What basal ganglia changes underlie the parkinsonian state? The significance of neuronal oscillatory activity (2013) (78)
- Selective D2 receptor stimulation induces dyskinesia in parkinsonian monkeys (1992) (78)
- Successful thalamic deep brain stimulation for orthostatic tremor (2008) (78)
- Computer keyboard interaction as an indicator of early Parkinson’s disease (2016) (74)
- Bilateral stimulation of the subthalamic nucleus has differential effects on reactive and proactive inhibition and conflict-induced slowing in Parkinson’s disease (2013) (74)
- Bone-marrow-derived cell differentiation into microglia: A study in a progressive mouse model of Parkinson's disease (2007) (74)
- The significance of defining preclinical or prodromal Parkinson's disease (2012) (72)
- Cortical activity preceding self‐initiated and externally triggered voluntary movement (1991) (71)
- Consequences of nigrostriatal denervation on the gamma-aminobutyric acidic neurons of substantia nigra pars reticulata and superior colliculus in parkinsonian syndromes (1996) (71)
- Blood-brain barrier opening with focused ultrasound in Parkinson’s disease dementia (2021) (71)
- In vitro α-synuclein neurotoxicity and spreading among neurons and astrocytes using Lewy body extracts from Parkinson disease brains (2017) (71)
- Progression of dopaminergic depletion in a model of MPTP-induced Parkinsonism in non-human primates. An 18F-DOPA and 11C-DTBZ PET study (2010) (70)
- The role of the subthalamic nucleus in the origin of hemiballism and parkinsonism: new surgical perspectives. (1997) (70)
- SARS-CoV-2 and the risk of Parkinson's disease: facts and fantasy (2020) (68)
- Randomized Trial of Focused Ultrasound Subthalamotomy for Parkinson's Disease. (2020) (67)
- Motor complications in Parkinson's disease: Striatal molecular and electrophysiological mechanisms of dyskinesias (2018) (67)
- Motor complications in Parkinson's disease and the clinical significance of rotational behavior in the rat: Have we wasted our time? (2006) (66)
- Effects of Nigrostriatal Denervation and L‐Dopa Therapy on the GABAergic Neurons of the Striatum in MPTP‐treated Monkeys and Parkinson's Disease: An In Situ Hybridization Study of GAD67 mRNA (1995) (64)
- Subthalamotomy improves MPTP-induced parkinsonism in monkeys. (1994) (63)
- Past, Present, and Future of the Pathophysiological Model of the Basal Ganglia (2011) (63)
- L-dopa-induced dyskinesia and stereotactic surgery for Parkinson's disease. (2008) (59)
- NMDA receptor GluN2A/GluN2B subunit ratio as synaptic trait of levodopa-induced dyskinesias: from experimental models to patients (2015) (58)
- Local administration of sarizotan into the subthalamic nucleus attenuates levodopa-induced dyskinesias in 6-OHDA-lesioned rats (2009) (57)
- The core assessment program for intracerebral transplantation. (1995) (56)
- Human striatal recordings reveal abnormal discharge of projection neurons in Parkinson’s disease (2016) (56)
- Beta activity in the subthalamic nucleus during sleep in patients with Parkinson's disease (2009) (55)
- Immunotherapy for neurological diseases. (2008) (55)
- New Sensor and Wearable Technologies to Aid in the Diagnosis and Treatment Monitoring of Parkinson's Disease. (2019) (54)
- The offset cortical potential: An electrical correlate of movement inhibition in man (1998) (53)
- Motor and non-motor circuit disturbances in early Parkinson disease: which happens first? (2021) (51)
- Ascorbate prevents cell death from prolonged exposure to glutamate in an in vitro model of human dopaminergic neurons (2013) (51)
- Inter-hemispheric asymmetry of nigrostriatal dopaminergic lesion: a possible compensatory mechanism in Parkinson’s disease (2011) (51)
- Neuronal vulnerability in Parkinson disease: Should the focus be on axons and synaptic terminals? (2019) (51)
- Subthalamic activity during diphasic dyskinesias in Parkinson's disease (2012) (50)
- MPTP-induced parkinsonism in primates: pattern of striatal dopamine loss following acute and chronic administration (1994) (50)
- Clinical Features, Pathophysiology, and Treatment of Levodopa-Induced Dyskinesias in Parkinson's Disease (2012) (48)
- Cabergoline in Parkinson's disease (1993) (48)
- Motor response to apomorphine and levodopa in asymmetric Parkinson's disease. (1994) (47)
- Anatomic and Neurophysiological Methods for the Targeting and Lesioning of the Subthalamic Nucleus: Cuban Experience and Review (2003) (46)
- Insights into Parkinson’s disease from computational models of the basal ganglia (2018) (45)
- The pathophysiology and pharmacology of photic cortical reflex myoclonus (1993) (45)
- Effects of L-DOPA-therapy on dopamine D2 receptor mRNA expression in the striatum of MPTP-intoxicated parkinsonian monkeys. (1996) (45)
- Reflex myoclonus in olivopontocerebellar atrophy. (1994) (44)
- Striatal activation by optogenetics induces dyskinesias in the 6‐hydroxydopamine rat model of Parkinson disease (2017) (44)
- Early administration of entacapone prevents levodopa-induced motor fluctuations in hemiparkinsonian rats (2005) (43)
- A direct projection from the subthalamic nucleus to the ventral thalamus in monkeys (2010) (43)
- Stimulation sites in the subthalamic nucleus and clinical improvement in Parkinson's disease: a new approach for active contact localization. (2016) (43)
- Reversible generalized dystonia and encephalopathy from thiamine transporter 2 deficiency (2012) (43)
- APOMORPHINE INFUSION FOR MOTOR FLUCTUATIONS IN PARKINSON'S DISEASE (1987) (43)
- Somatosensory evoked potentials: abnormalities with focal brain lesions remote from the primary sensorimotor area. (1980) (42)
- Abnormal pattern of brain glucose metabolism in Parkinson’s disease: replication in three European cohorts (2019) (41)
- The AMPA receptor antagonist NBQX does not alter the motor response induced by selective dopamine agonists in MPTP-treated monkeys. (1993) (39)
- Significance of visual hallucinations and cerebral hypometabolism in the risk of dementia in Parkinson's disease patients with mild cognitive impairment (2016) (39)
- Cognitive and neuropsychiatric effects of subthalamotomy for Parkinson's disease. (2010) (38)
- The globus pallidus pars externa and Parkinson's disease. Ready for prime time? (2006) (37)
- Autoradiographic localization and density of [125I]ferrotransferrin binding sites in the basal ganglia of control subjects, patients with Parkinson's disease and MPTP-lesioned monkeys (1995) (36)
- Longitudinal assessment of the pattern of cognitive decline in non-demented patients with advanced Parkinson's disease. (2014) (36)
- Hardware complications in deep brain stimulation: electrode impedance and loss of clinical benefit. (2012) (36)
- Lesion of the centromedian thalamic nucleus in MPTP‐treated monkeys (2008) (35)
- Levodopa-induced dyskinesias in Parkinson's disease. (2007) (35)
- Different levodopa actions on the extracellular dopamine pools in the rat striatum (2007) (34)
- Scaled Subprofile Modeling and Convolutional Neural Networks for the Identification of Parkinson's Disease in 3D Nuclear Imaging Data (2019) (34)
- Reduced noradrenaline, but not dopamine and serotonin in motor thalamus of the MPTP primate: relation to severity of Parkinsonism (2013) (34)
- Statistical parametric maps of 18F-FDG PET and 3-D autoradiography in the rat brain: a cross-validation study (2011) (32)
- Continuous Dopaminergic Stimulation as a Treatment for Parkinson's Disease: Current Status and Future Opportunities (2020) (31)
- Neuronal activity of the red nucleus in Parkinson's disease (2008) (30)
- Neuromelanin accumulation with age in catecholaminergic neurons from Macaca fascicularis brainstem. (1993) (29)
- Antimyoclonic action of piracetam. (1986) (29)
- Time interval between repeated injections conditions the duration of motor improvement to apomorphine in Parkinson's disease (1992) (28)
- Differences in the Motor Response to Apomorphine Between Untreated and Fluctuating Patients With Parkinson's Disease (1992) (28)
- Coadministration of entacapone with levodopa attenuates the severity of dyskinesias in hemiparkinsonian rats (2006) (28)
- Cortical disinhibition in Parkinson's disease. (2020) (27)
- Subthalamotomy for Parkinson’s disease: clinical outcome and topography of lesions (2017) (26)
- Dopamine agonists suppress visual-cortical reflex myoclonus. (1985) (25)
- Behavioral tolerance to repeated apomorphine administration in parkinsonian monkeys (1993) (25)
- The place of COMT inhibitors in the armamentarium of drugs for the treatment of Parkinson's disease. (2000) (25)
- Transcranial Magnetic Resonance-Guided Focused Ultrasound Thalamotomy in Essential Tremor: A Comprehensive Lesion Characterization. (2020) (24)
- Identification of distinct pathological signatures induced by patient-derived α-synuclein structures in nonhuman primates (2020) (24)
- Glutamic acid decarboxylase mRNA expression in medial and lateral pallidal neurons in the MPTP-treated monkey and patients with Parkinson's disease. (1996) (24)
- Effect of deep brain stimulation of the subthalamic nucleus on non-motor fluctuations in Parkinson's disease: two-years' follow-up. (2013) (24)
- Chronic MPTP treatment reduces substance P and met-enkephalin content in the basal ganglia of the marmoset (1992) (24)
- LRRK2 haplotype‐sharing analysis in Parkinson's disease reveals a novel p.S1761R mutation (2012) (24)
- Neurophysiological assessment of alpha pattern coma. (1980) (23)
- Remote Monitoring of Treatment Response in Parkinson's Disease: The Habit of Typing on a Computer (2019) (23)
- Aggravation of Parkinson's disease by cinnarizine. (1987) (23)
- Cortical mechanisms mediating asterixis (1992) (23)
- Differential vulnerability to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine of dopaminergic and cholinergic neurons in the monkey mesopontine tegmentum (1993) (23)
- New MRI, 18F-DOPA and 11C-(+)-α-dihydrotetrabenazine templates for Macaca fascicularis neuroimaging: Advantages to improve PET quantification (2009) (22)
- Parkinson’s disease with mild cognitive impairment: severe cortical thinning antedates dementia (2019) (22)
- Dyskinesias induced by subthalamotomy in Parkinson’s disease are unresponsive to amantadine (2006) (22)
- Neuronal activity in the substantia nigra in the anaesthetized rat has fractal characteristics. Evidence for firing-code patterns in the basal ganglia (2003) (22)
- Firing regulation in dopaminergic cells: effect of the partial degeneration of nigrostriatal system in surviving neurons (2003) (22)
- Micrographia secondary to lenticular haematoma. (1988) (22)
- Continuous Dopaminergic Stimulation in Parkinson’s Disease (1988) (21)
- Monoaminergic PET imaging and histopathological correlation in unilateral and bilateral 6-hydroxydopamine lesioned rat models of Parkinson's disease: A longitudinal in-vivo study (2015) (21)
- Melevodopa/carbidopa effervescent formulation in the treatment of motor fluctuations in advanced Parkinson's disease (2010) (21)
- The parafascicular thalamic complex and basal ganglia circuitry: further complexity to the basal ganglia model (2002) (20)
- Is executive control used to compensate for involuntary movements in levodopa‐induced dyskinesia? (2012) (19)
- Dopaminergic Vulnerability in Parkinson Disease: The Cost of Humans’ Habitual Performance (2019) (19)
- Surgical treatment of Parkinson's disease. (2003) (19)
- Dopamine-dependent changes of cortical excitability induced by transcranial static magnetic field stimulation in Parkinson’s disease (2017) (19)
- Microstructural changes of the dentato‐rubro‐thalamic tract after transcranial MR guided focused ultrasound ablation of the posteroventral VIM in essential tremor (2019) (19)
- Focused ultrasound in Parkinson's disease: A twofold path toward disease modification (2019) (19)
- Bilateral staged magnetic resonance-guided focused ultrasound thalamotomy for the treatment of essential tremor: a case series study (2021) (18)
- How is firing activity of substantia nigra cells regulated? Relevance of pattern‐code in the basal ganglia (2003) (18)
- The use of nonhuman primate models to understand processes in Parkinson’s disease (2018) (18)
- Functional impact of subthalamotomy by magnetic resonance–guided focused ultrasound in Parkinson’s disease: a hybrid PET/MR study of resting-state brain metabolism (2019) (18)
- Bromocriptine and lisuride in dystonias (1984) (18)
- Levodopa‐responsive parkinsonism associated with basal ganglia calcification and primary hypoparathyroidism (1993) (18)
- Levodopa toxicity and Parkinson disease (2011) (18)
- Concomitant short‐ and long‐duration response to levodopa in the 6‐OHDA‐lesioned rat: a behavioural and molecular study (2007) (17)
- Changes in thalamic dopamine innervation in a progressive Parkinson's disease model in monkeys (2019) (17)
- Clinical aspects of negative myoclonus. (1995) (17)
- Striatal interaction among dopamine, glutamate and ascorbate (2012) (17)
- Therapy of myoclonus. (1995) (17)
- Lesion of the basal ganglia and surgery for Parkinson disease. (2001) (17)
- Deep brain stimulation for Parkinson's disease: Thinking about the long‐term in the short‐term (2011) (17)
- Basal ganglia, Parkinson's disease and levedopa therapy (2000) (16)
- Mass spectrometric characterization of mitochondrial complex I NDUFA10 variants (2008) (16)
- Subcutaneous administration of lisuride in the treatment of complex motor fluctuations in Parkinson's disease. (1988) (16)
- Analysis of the GIGYF2 gene in familial and sporadic Parkinson disease in the Spanish population (2010) (16)
- Excitatory responses in the ‘direct’ striatonigral pathway: Effect of nigrostriatal lesion (2000) (16)
- Catechol-O-methyltransferase inhibitors in preclinical models as adjuncts of L-dopa treatment. (2010) (16)
- Modeling clinical features of neurodegeneration. (2010) (16)
- Overcoming pharmacokinetic problems in the treatment of parkinson's disease (1989) (16)
- Levodopa and 3-O-methyldopa plasma levels in parkinsonian patients with stable and fluctuating motor response. (1989) (15)
- Levodopa therapy for Parkinson's disease: Challenges and future prospects (2008) (14)
- Is dopaminergic cell death accompanied by concomitant nerve plasticity? (1996) (14)
- Neuroleptic malignant syndrome treated with subcutaneous lisuride infusion (1990) (14)
- Abnormal muscle and skin mitochondria in family with myoclonus, ataxia, and deafness (May and White syndrome). (1992) (14)
- In situ hybridization of GAD mRNA in monkey and human brain: quantification at both regional and cellular levels (1993) (13)
- Striatal dopamine function in a family with multiple SCA-3 phenotypes (2011) (13)
- Use of 11C-(+)-α-dihydrotetrabenazine for the assessment of dopaminergic innervation in animal models of Parkinson's disease (2008) (13)
- Unilateral subthalamotomy in Parkinson's disease: Cognitive, psychiatric and neuroimaging changes (2017) (13)
- Compensatory mechanisms in Parkinson's disease (2009) (13)
- Focused ultrasound thalamotomy for multiple sclerosis–associated tremor (2020) (13)
- Entacapone potentiates the long-duration response but does not normalize levodopa-induced molecular changes (2008) (13)
- Editorial: Parkinson's disease: cell vulnerability and disease progression (2015) (12)
- Static magnetic field stimulation of the supplementary motor area modulates resting-state activity and motor behavior (2019) (12)
- Levodopa consumption reduces dopaminergic receptor responsiveness in Parkinson's disease. (1989) (12)
- Motor Onset Topography and Progression in Parkinson's Disease: the Upper Limb Is First (2021) (12)
- Urea-induced stimulus-sensitive myoclonus in the rat. (1986) (12)
- Unilateral pallidotomy in 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐treated common marmosets exhibiting levodopa‐induced dyskinesia (2005) (12)
- Continuing efforts to obtain continuous delivery of levodopa (2011) (12)
- Gangliosides and parkinsonism (1993) (12)
- Reduced habit-driven errors in Parkinson’s Disease (2018) (11)
- Early L-dopa, but not pramipexole, restores basal ganglia activity in partially 6-OHDA-lesioned rats (2014) (11)
- Machine Learning Based Analysis of FDG-PET Image Data for the Diagnosis of Neurodegenerative Diseases (2018) (11)
- Neurotoxicity induced by prenatal exposure to MPTP on the monoaminergic and peptidergic systems of the marmoset brain (1995) (11)
- [Use of 11C-(+)-alpha -dihydrotetrabenazine for the assessment of dopaminergic innervation in animal models of Parkinson's disease]. (2008) (11)
- Can levodopa-induced dyskinesias go beyond the motor circuit? (2015) (11)
- Parenteral administration of lisuride in Parkinson's disease. (1987) (11)
- Serotonergic innervation of the striatum in a nonhuman primate model of Parkinson's disease (2020) (11)
- Motor response to repeated dopaminergic stimulation in Parkinson's disease. (1992) (10)
- [Optimization of use of levodopa in Parkinson's disease: role of levodopa-carbidopa-entacapone combination]. (2005) (10)
- Coprolalia associated with hemiballismus: response to tetrabenazine. (1985) (10)
- Short- and long-term effects induced by repeated 6-OHDA intraventricular administration: A new progressive and bilateral rodent model of Parkinson’s disease (2017) (10)
- Where does chorea come from? Cortical excitability findings challenge classic pathophysiological concepts (2015) (10)
- Functional Topography of the Human Subthalamic Nucleus: Relevance for Subthalamotomy in Parkinson's Disease (2021) (9)
- Subthalamic 6-OHDA-induced lesion attenuates levodopa-induced dyskinesias in the rat model of Parkinson's disease (2013) (9)
- Pain and dyskinesia in Parkinson's disease (2010) (9)
- Generalized reflex myoclonus in a patient with alcohol‐sensitive spontaneous myoclonus and an abnormal gait (1990) (9)
- The duration of the motor response to apomorphine boluses is conditioned by the length of a prior infusion in Parkinson's disease (2009) (8)
- Letter: The Role of Skull Thickness Beyond the Skull Density Ratio on MRgFUS Thalamotomy Feasibility: Which Patients Should We Exclude? (2020) (8)
- Early Paradoxical Increase of Dopamine: A Neurochemical Study of Olfactory Bulb in Asymptomatic and Symptomatic MPTP Treated Monkeys (2017) (8)
- Deep Brain Stimulation of the Globus Pallidus Pars Interna and Subthalamic Nucleus in Parkinson's Disease: Pros and Cons (2008) (8)
- The Movement Disorders journal 2016 and onward (2016) (8)
- Neurobiology of Disease Coupling between Beta and High-Frequency Activity in the Human Subthalamic Nucleus May Be a Pathophysiological Mechanism in Parkinson ’ s Disease (2010) (8)
- Subthalamic role on the generation of spikes in temporal epilepsy (2009) (8)
- [Quick and simple synthesis of (11)C-(+)-alpha-dihydrotetrabenazine to be used as a PET radioligand of vesicular monoamine transporters]. (2008) (8)
- Habitual behavior and dopamine cell vulnerability in Parkinson disease (2015) (8)
- Static magnetic field stimulation of the supplementary motor area modulates resting-state activity and motor behavior (2019) (7)
- The Vatican Meeting on Neuroprotection for Parkinson's Disease (2013) (7)
- Movement disorders: improved understanding of early disease (2013) (7)
- Levodopa–induced dyskinesias in the absence of nigrostriatal degeneration (2013) (7)
- Acetazolamide improves action myoclonus in Ramsay Hunt syndrome. (1992) (7)
- Movement disorders—a growing journal for a growing field (2014) (7)
- Editors' Note: The 200th Anniversary of the Shaking Palsy (2017) (7)
- Deep brain stimulation for parkinson's disease and tremor (2000) (6)
- Lithium therapy in torsion dystonia (1982) (6)
- Striatal Blood–Brain Barrier Opening in Parkinson's Disease Dementia: A Pilot Exploratory Study (2022) (6)
- Motor manifestations and basal ganglia output activity: The paradox continues (2013) (6)
- Brain injections of glial cytoplasmic inclusions induce a multiple system atrophy-like pathology. (2022) (6)
- Pure motor quadriplegia secondary to bilateral capsular hematomas. (1980) (6)
- Intralaminar Thalamic Nuclei are Main Regulators of Basal Ganglia (2005) (6)
- Neurotoxic effect of prenatal exposure to MPTP on the dopaminergic systems of the marmoset brain. (1992) (6)
- Pooled-DNA target sequencing of Parkinson genes reveals novel phenotypic associations in Spanish population (2018) (6)
- [125I]EGF Binding in Basal Ganglia of Patients with Parkinson's Disease and Progressive Supranuclear Palsy and in MPTP-Treated Monkeys (1998) (6)
- Technical advances in deep brain stimulation: How far is enough? (2012) (6)
- Cognitive safety after unilateral magnetic resonance-guided focused ultrasound thalamotomy for essential tremor (2019) (6)
- Role of the Subthalamic Nucleus in Normal and Pathological Conditions (1994) (6)
- Neuroimaging signatures predicting motor improvement to focused ultrasound subthalamotomy in Parkinson’s disease (2022) (5)
- Differentiating Early and Late Stage Parkinson’s Disease Patients from Healthy Controls (2016) (5)
- Long-term effect of unilateral subthalamotomy for Parkinson’s disease (2019) (5)
- 18FDOPA striatal uptake in Macaca fascicularis monkeys: Methodological development for a Mosaic microPET scanner (2006) (5)
- Neuron types in the primate striatum: Stereological analysis of projection neurons and interneurons in control and parkinsonian monkeys (2022) (5)
- The Role of Focused Ultrasound in the Management of Movement Disorders: Insights after 5 Years of Experience (2021) (5)
- Letter to the editor: Parkinson's disease and early subthalamotomy. (2015) (5)
- Parkinson's disease and thalamus: facts and fancy (2016) (5)
- [Parkinsonism induced by MPTP as an experimental model of Parkinson disease: similarities and differences]. (1991) (5)
- Parkinson's Disease: Cell Vulnerability and Disease Progression (2015) (5)
- Compensatory Mechanisms in Experimental and Human Parkinsonism (2009) (5)
- [Motor fluctuations in Parkinson disease: risk factors]. (1992) (5)
- Movement Disorders – Twenty‐Five years . . . and Still Growing (2011) (5)
- [Visual evoked potentials in Parkinson disease]. (1986) (5)
- DBS for Parkinson's disease with behavioural disturbances (2018) (4)
- 2018 message from the editor in chief—Movement Disorders journal at cruise speed (2018) (4)
- Amantadine may be useful in essential tremor (1986) (4)
- Present and future of subthalamotomy in the management of Parkinson´s disease: a systematic review (2021) (4)
- Coexisting Parkinson’s and Wilson’s Disease: Chance or Connection? (2016) (4)
- Delayed onset dystonia. (1985) (3)
- l‐dopa‐induced dyskinesias in unilateral 6‐hydroxydopamine‐lesioned rats are not modified by excitotoxic lesion of the entopeduncular nucleus and substantia nigra pars reticulata (2013) (3)
- Chapter 5 – Clinical Features, Pathophysiology and Management of Motor Complications in Parkinson's Disease (2005) (3)
- Neuronal discharge patterns in the Globus Pallidus pars interna in a patient with Parkinson’s disease and hemiballismus secondary to subthalamotomy (2011) (3)
- On the meaning of a monophasic positive somatosensory evoked potential in deep coma. (1980) (3)
- Onset pattern of nigrostriatal denervation in early Parkinson's disease. (2022) (3)
- Erratum: Levodopa in the treatment of Parkinson's disease: Current controversies (Movement Disorders) (2004)) (2005) (3)
- Understanding motor control in health and disease: classic single (n = 1) observations (2020) (3)
- Stem cell therapy for Parkinson's disease (2012) (3)
- Habitual behavior and dopamine cell vulnerability in Parkinson disease (2015) (3)
- Editor's Note: Pathophysiology of the Basal Ganglia Grows in Understanding and Complexity but Essential Unknown Remains (2019) (3)
- Transient dopamine neuron activity precedes and encodes the vigor of contralateral movements (2021) (3)
- Compensatory Mechanisms in Experimental and Human Parkinsonism: Potential for New Therapies Chapter 37 (2010) (3)
- Functional Organization of the Basal Ganglia: Dopaminergic and Non‐Dopaminergic Features (2011) (3)
- Functional Models of the Basal Ganglia: Where Are We? (2000) (3)
- Features and Mechanisms of Diphasic Dyskinesia in Parkinson’s Disease (2014) (3)
- Somatosensory evoked potentials: abnormalities in brainstem lesions. (1979) (3)
- Medical treatment of tremor in Parkinson’s disease (1984) (3)
- Toxic myoclonus. (1986) (3)
- The basal ganglia and new surgical approaches for Perkinson's disease (1997) (3)
- Pathophysiological Mechanisms The Basal Ganglia and Disorders of Movement : (2002) (3)
- Subthalamotomy in Parkinson's Disease (2009) (2)
- The baton is passed (2010) (2)
- [Pseudomigraine with inflammatory cerebrospinal fluid: a benign syndrome]. (1984) (2)
- Scientific perspectives (2014) (2)
- Computer-Based Visualization System for the Study of Deep Brain Structures Involved in Parkinson’s Disease (2015) (2)
- Low‐Frequency Oscillations at The Limbic Globus Pallidus Internus Seem to Be Associated With Premonitory Urges in Tourette's Syndrome (2021) (2)
- [Physiopathology of Parkinson disease]. (1998) (2)
- [Alexia without agraphia, right homonymous hemianopsia, and color anomia. Report of four cases with location of the lesion by computerized axial tomography of the brain (author's transl)]. (1981) (2)
- [Guillain-Barré syndrome associated to a type B acute hepatitis (author's transl)]. (1979) (2)
- The role of comt inhibitors in the treatment of Parkinson's disease (2000) (2)
- European Academy of Neurology/Movement Disorder Society-European Section Guidelines on Pallidotomy for Parkinson's Disease: Let's Be Accurate. (2022) (2)
- Levodopa-induced dyskinesias - Foreword (2000) (2)
- Identification of distinct pathological signatures induced by patient-derived α-synuclein structures in non-human primates (2019) (2)
- EAN/MDS-ES Guidelines on pallidotomy for Parkinson´s disease: Let´s be accurate. (2022) (2)
- Continuous dopaminergic stimulation for Parkinson's disease: facts and fancy. (1988) (2)
- [Experimental model of Parkinson disease: mechanisms and anatomo- pathological characteristics of MPTP neurotoxicity]. (1992) (2)
- Urea infusion in the rat produces stimulus sensitive myoclonus (1981) (2)
- Editor's note: Prodromal Parkinson's disease (2019) (2)
- Rest tremor in Parkinson’s disease: the theta and beta sides of the coin (2020) (2)
- Neuronal death and Parkinson's disease (1999) (2)
- Cerebral metabolic pattern associated with progressive parkinsonism in non-human primates reveals early cortical hypometabolism (2022) (2)
- Home-based transcranial static magnetic field stimulation of the motor cortex for treating levodopa-induced dyskinesias in Parkinson's disease: A randomized controlled trial (2022) (2)
- BBB opening with focused ultrasound in nonhuman primates and Parkinson’s disease patients: Targeted AAV vector delivery and PET imaging (2023) (1)
- Deep Brain Stimulation and Parkinson’s Disease (2009) (1)
- Commentary on reversible pseudoathetosis induced by cervical myelopathy (2012) (1)
- Assessment of central conduction in somatosensory pathways. (1980) (1)
- Somatosensory evoked potentials in focal brain lesions (1980) (1)
- Evolution of Parkinson's Disease and Treatment Requirements: What New Treatments are Needed and the Role of Striatal Grafting (2006) (1)
- Author Correction: Computer keyboard interaction as an indicator of early Parkinson’s disease (2018) (1)
- REVIEW (1994) (1)
- Editor's note: Huntington's disease: One gene, one protein, one effective therapy. What is wrong (or not so simple)? (2019) (1)
- Profile of Mahlon DeLong and Alim Benabid, 2014 Lasker-DeBakey Medical Research Awardees (2014) (1)
- New Routes of Administration for Antiparkinsonian Therapy (1989) (1)
- What Would Dr. James Parkinson Think Today? I. The Role of Functional Neurosurgery for Parkinson's Disease (2017) (1)
- Topography of giant somatosensory evoked potentials to median nerve stimulation in cortical myoclonus (1990) (1)
- FC26.2 Is orthostatic tremor of cortical origin? (2006) (1)
- Preventing levodopa-induced dyskinesias. Discussion (2000) (1)
- Editor's note: Functional movement disorders: The pendulum keeps moving (2019) (1)
- Prospective Long-term Follow-up of Focused Ultrasound Unilateral Subthalamotomy for Parkinson Disease (2023) (1)
- [Subdural hematoma: an infrequent cause of asterixis]. (1986) (1)
- New MRI , 18 F-DOPA and 11 C-( + )-α-dihydrotetrabenazine templates for Macaca fascicularis neuroimaging : Advantages to improve PET quanti fi cation (2009) (1)
- Functions of the basal ganglia—paradox or no paradox? (2016) (1)
- Editor's Note: Deep Brain Stimulation and Functional Neurosurgery for Movement Disorders: Is the Current Cycle Waning? (2019) (1)
- Functional Anatomy and Pathophysiology of the Basal Ganglia (2010) (1)
- Progabide in Parkinson's disease (1987) (1)
- 2012 impact factor increases to 4.558 (2013) (1)
- The motor inhibitory network in patients with asymmetrical Parkinson’s disease: An fMRI study (2022) (1)
- CHAPTER 2:Molecular Pathogenesis and Pathophysiology of Parkinson’s Disease: New Targets for New Therapies (2013) (1)
- [Oral lisuride in Parkinson's disease]. (1985) (1)
- [Routes and systems involved in the origin of somatosensory evoked potentials in man]. (1979) (1)
- [Olivopontocerebellar atrophy and Parkinson's disease: diagnostic problems]. (1994) (1)
- The End of a Cycle: A Unique Perspective in the Evolution of Movement Disorders (2019) (1)
- We are what we eat — editors’ note on the role of diet in Parkinson's disease (2019) (1)
- [Alcoholism, polyneuropathy, and liver disease. A prospective electrophysiologic study]. (1981) (1)
- Treatment should not be initiated too soon in Parkinson's disease - Reply (2006) (0)
- Letters to the editor (0)
- An advanced visualization system for the neurofunctional study of Parkinson's disease (2014) (0)
- Deep-brain stimulation in Parkinson's disease [2] (multiple letters) (2002) (0)
- Bilateral stimulation of the subthalamic nucleus has differential effects on reactive and proactive inhibition and conflict-induced slowing in Parkinson’s disease (2013) (0)
- assessment ofalpha pattern coma (1980) (0)
- O.023 Advances in basal ganglia functional organization (2009) (0)
- [Correlation of somatosensory evoked potential electroencephalogram: quantitative study]. (1979) (0)
- Response from dual perspectives companion (2017) (0)
- O.028 The spectrum of clinical manifestations of basal ganglia disorders: a challenge for any new model (2009) (0)
- OBESO, Jose: Madrid/Spain (2019) (0)
- Retraction: ‘Alendronate and vitamin D2 for prevention of hip fracture in Parkinson’s disease: A randomized controlled trial,’ by Sato, Y., Iwamoto, J., Kanoko, T., and Satoh, K. (2016) (0)
- [Diabetic neuropathy: etiology, diagnosis and evolution]. (1979) (0)
- The end of the term (2014) (0)
- What would Dr. James Parkinson think today? The 21st Annual Congress of the International Parkinson's disease and movement disorders society (2017) (0)
- Reduced habit-driven errors in Parkinson’s Disease (2019) (0)
- [Evaluation and diagnosis of torsion dystonia]. (1991) (0)
- Editor's note: The origin of Parkinson's disease: The importance of environment and lifestyle (2019) (0)
- Levodopa therapy and motor fluctuations in Parkinson's disease (1988) (0)
- [Anatomo-functional basis for Parkinson's disease]. (1991) (0)
- [Conduction and origin of evoked potentials in the somesthetic pathway (author's transl)]. (1981) (0)
- European Academy of Neurology/Movement Disorder Society-European Section´s Guidelines on pallidotomy for Parkinson´s disease: Let´s remain accurate. (2022) (0)
- Blood-brain barrier opening with focused ultrasound in Parkinson’s disease dementia (2021) (0)
- Neuroimaging signatures predicting motor improvement to focused ultrasound subthalamotomy in Parkinson’s disease (2022) (0)
- [Medullar and supraspinal conduction in multiple sclerosis: localization value (author's transl)]. (1980) (0)
- Parkinson’s disease with mild cognitive impairment: severe cortical thinning antedates dementia (2017) (0)
- A changing journal for a changing field (2010) (0)
- [Orally administered lisuride in the treatment of complex fluctuations of motion in Parkinson disease]. (1989) (0)
- Reply to: Motor Features in a Peruvian Cohort of Parkinson's Disease Patients (2021) (0)
- Movement Disorders Journal: Yesterday, Today, Tomorrow, and Always (2019) (0)
- Meeting Report Problems and Solutions for Circuits and Synapses in Parkinson's Disease (2004) (0)
- [Alterations of previous potentials of somatosensory cerebral evoked potential after lesions of the brain-stem (author's transl)]. (1980) (0)
- Letter to the editor (0)
- Corrigendum: Habitual Behavior and Dopamine Cell Vulnerability in Parkinson Disease (2015) (0)
- Commentary (2013) (0)
- Editor's tribute: Dr. Robert Burke (2018) (0)
- Dopaminergic deficit compensation and molecular changes in the basal ganglia in a progressive MPTP monkey model. (2010) (0)
- Matters arising Recurrent intracranial haemorrhage in Behcet disease (0)
- The state of the journal—2013 (2013) (0)
- The Latest News in Movement Disorders: Steps Forward and Back (2014) (0)
- TUO11 Changes in the activity of the basal ganglia during movement observation (2008) (0)
- The progression of dopaminergic depletion in unilateral 6-OHDA-lesioned rats: PET imaging and histopathologic studies. | 8th FENS Forum of Neuroscience (14-18 July 2012. Barcelona, Spain) (2012) (0)
- 16 – Temporal discrimination and bradykinesia in Parkinson's disease (1990) (0)
- P7.9 Subthalamic activity during a motor inhibition task (2011) (0)
- Comprar Movement Disorders + Dvd | Ray L. Watts | 9780071613101 | Mcgraw-Hill Education (2011) (0)
- Disclosures to the special issue: The vatican conference on neuroprotection in Parkinson's disease volume 28, issue 1, january 2013 (2013) (0)
- [Amyotrophic neuralgia and Addison's disease]. (1991) (0)
- THE AMPA ANTAGONIST NBQX DOES NOT ALTER THE MOTOR RESPONSE INDUCED BY SELECTIVE DOPAMINE AGONISTS IN MPTP-MONKEYS (1992) (0)
- Basal ganglia compensatory mechanisms of dopaminergic deficit: Early changes in the MPTP monkey model (2011) (0)
- The primate striatum: morphological and stereological study of neurons and interneurons in the MPTP non-human primate model (2021) (0)
- MATTERS ARISING (1994) (0)
- Reply (2006) (0)
- Book review: Marsden's Book of Movement Disorders. (2012) (0)
- Letters to the Editor (0)
- Concerns about the European Academy's Recommendations and Guidelines Regarding Pallidotomy for Parkinson's Disease (2023) (0)
- DOPAMINE AND SEROTONIN DEPLETION IN THE BRAIN OF MARMOSETS PRENATALLY EXPOSED TO MPTP (1992) (0)
- The Movement Disorders journal—Then and now (2011) (0)
- Major advances in Parkinson's disease over the past two decades and future research directions (2022) (0)
- Basal Ganglia, Diseases of (2003) (0)
- The contribution of C. David Marsden to the study and treatment of myoclonus. (2002) (0)
- Movement disorders. (1992) (0)
- disease . levodopa in asymmetric Parkinson ' s Motor response to apomorphine and (0)
- Editor's note: This is nature speaking to us in a language we don't understand (2019) (0)
- Effects of deep brain stimulation of the subthalamic nucleus on inhibition and response initiation under conflict in Parkinson’s Disease (2009) (0)
- [Cerebral implants in Parkinson's disease]. (1989) (0)
- Movement disorders. (1997) (0)
- Monoaminergic and metabolic Positron Emission Tomography of unilateral and bilateral 6-OHDA rat models of Parkinson's disease: a longitudinal in-vivo study. | 15º Congreso Nacional de laSociedad Española de NeuroCiencia (25-27 de Septiembre de 2013. Oviedo, Spain) (2013) (0)
- To lesion or not to lesion: That was the question (Reply to “stereotactic ablative surgery does not just mean ‘adding another lesion’”) (2017) (0)
- Conclusions (2018) (0)
- P306: Association of subthalamic activity with clinical and demographical parameters in a large cohort of Parkinson’s disease patients (2011) (0)
- Ghost writing and conflict of interest — Editor's comments (2018) (0)
- Dopaminergic photosensitivity (1991) (0)
- In memoriam Professor Edward Robert Hitchcock. NECTAR members. (1994) (0)
- Movement disorders. (1996) (0)
- Concerns About the European Academy's Recommendations and Guidelines Regarding Pallidotomy for Parkinson's Disease (2023) (0)
- Evidence-Based Reviews and Guidelines: Let's Avoid Future Confusion. (2022) (0)
- Editor's Note: Movement Disorders One Decade Ago, One Decade Ahead (2019) (0)
- Using Graph Theory to Identify Aberrant Hierarchical Patterns in Parkinsonian Brain Networks (2013) (0)
- Cover Image, Volume 48, Issue 5 (2022) (0)
- The Movement Disorders Journal Conference 2018 (2018) (0)
- ["Neurorestorative" cell therapy in Parkinson's disease: an unresolved debate]. (2004) (0)
- Determinants of selective neuronal vulnerability in Parkinson's disease (2021) (0)
- The Movement Disorders Journal 2015 and onwards: Tradition changes, the challenges remain the same (2015) (0)
- Cabergoline in Parkinson's disease (1995) (0)
- PS-14-4 Is there a “Bereitschaftspotential” prior to cessation of a voluntary movement? (1995) (0)
- [Bilateral asymmetric degeneration of the striatum as a cause of senile hemiballism]. (1997) (0)
- P123 Spontaneous high-frequency oscillations recorded in the vicinity of the thalamus and subthalamic nucleus (2008) (0)
- Letters to the editor (1995) (0)
- [Motor complications in patients with Parkinson disease treated with levodopa]. (1989) (0)
- P3.068 Basal ganglia hyperindirect pathway: direct projections from the subthalamic nucleus innervating the ventral motor thalamic nuclei in MPTP-treated primates (2009) (0)
- A 1 Compensatory mechanisms and motor functions of the basal ganglia : lessons from Parkinson ́ s disease (2004) (0)
- [Cellular transplants for Parkinson's disease]. (1991) (0)
- Impact factor for 2013 (2014) (0)
- Selective activation of striatal indirect pathway suppresses levodopa induced-dyskinesias (2022) (0)
- Movement Disorders 2011 – The State of the Journal (2011) (0)
- In Vivo Growing of New Cell Colonies in a Portion of Bone Marrow: Potential Use for Indirect Cell Therapy. (2010) (0)
- Reply to: “Being too inclusive about synuclein inclusions” (2010) (0)
- Dopamine innervation of the mediodorsal and reticular thalamic nuclei in MPTP parkinsonian monkeys. (2018) (0)
- P5-2 Theta subthalamic activity in impulse control disorders in Parkinson disease (2010) (0)
- Subject Index Vol. 62, 1994 (1994) (0)
- Prof. E. Hitchcock (1994) (0)
- Parkinson's disease and early subthalamotomy (2015) (0)
- Dopamine-dependent changes of cortical excitability induced by transcranial static magnetic field stimulation in Parkinson’s disease (2017) (0)
- Movement disorders journal conference 2018: Neuronal vulnerability in Parkinson's disease (2019) (0)
- Disabling Postural and Resting Tremor: What Should One Aim to Treat? (2012) (0)
- New Sections for Movement Disorders (2011) (0)
- Motor and non-motor circuit disturbances in early Parkinson disease: which happens first? (2021) (0)
- Editor's Note: The Beauty and Convenience of Simplicity: Will It Help Enlighten Our Understanding of Progressive Supranuclear Palsy? (2019) (0)
- [Acute polyradiculoneuritis and amyotrophic neuralgia in Addison's disease]. (1981) (0)
- Reply to Montgomery (2009) (0)
- In Reply: Randomized Trial of Unilateral Focused Ultrasound Subthalamotomy for Parkinson Disease. (2021) (0)
- Paradox of the Basal Ganglia Model: The Antidyskinetic Effect of Surgical Lesions in Movement Disorders (2009) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With José Angel Obeso?
José Angel Obeso is affiliated with the following schools:
